Cyclooxygenase-2 promoter polymorphism -899G/C is associated with hepatitis B-related liver cancer in a Chinese population of Gansu province

Chinese Medical Journal

Volumn 124, Issue 24, 2011, Pages 4193-4197

  He, Jian Hong ^a   Li, Yu Min ^a,b   Zhang, Quan Bao ^a   Ren, Zhi Jian ^a,b   Li, Xun ^a   Zhou, Wen Ce ^a   Zhang, Hui ^a   Meng, Wen Bo ^a   He, Wen Ting ^b  

^a LANZHOU UNIVERSITY   (China)

^b Key Laboratory of Digestive System Tumors of Gansu Province   (China)

Author keywords

Cyclooxygenase 2; Hepatitis B related liver cancer; Polymorphisms

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CHINESE; CHRONIC HEPATITIS; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; FEMALE; GENE FREQUENCY; GENE PROBE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEPATITIS B; HETEROZYGOTE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CYCLOOXYGENASE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 84862971758     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.24.014     Document Type: Article

References (25)

1. Lo CM, Liu CL, Chan SC, Lam CM, Poon RT, Ng IO, et, al. A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg 2007; 245: 831-842.
2. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: 5-16.
3. El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002; 35: 72-78.
4. Lai J, Gao ZL, Yang L, Chen W, Zhou X, Ke WM. Correlation of genetic polymorphisms of beta-catenin to hepatitis B virus-related hepatocellular carcinoma. Chin J Ca (Chin) 2009; 28: 607-611.
5. Meng W, Lu H, Cai R, Jiang F, Jiang Q, Lin W, et al. A study on the genetic epidemiology of hepatocellular carcinoma. Chin J Epidemiol (Chin) 2002; 23: 438-440.
6. Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mttal B. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma. Mutat Res 2009; 663: 52-59.
7. Pereira C, Sousa H, Ferreira P, Fragoso M, Moreira-Dias L, Lopes C, et al. -765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia. World J Gastroenterol 2006; 12: 5473-5478.
8. Strillacci A, Griffoni C, Sansone P, Paterini P, Piazzi G, Lazzarini G, et al. MR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res 2009; 315: 1439-1447.
9. Zhou ZG, Wu XJ, Li LR, Peng ZH, Ding PR, Wang RJ, Pan ZZ. A multivariate analysis of prognostic determinants for stages II and III colorectal cancer in 141 patients. Chin Med J 2011; 124: 2132-2135.
10. Li F, Ren GS, Li HY, Wang XY, Chen L, Li J. A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer. Clin Oncol (R Coll Radiol) 2009; 21: 302-305.
11. Zhang H, Lin Y Xiao Y, Wang SM, Liu XX, Wang SM. Stable transfection of estrogen receptor-alpha suppresses expression of cyclooxygenase-2 and vascular endothelial growth factor-C in MDA-MB-231 breast cancer cells. Chin Med J 2010; 123: 1989-1994.
12. Giannitrapani L, Ingrao S, Soresi M, Florena AM, La Spada E, Sandonato L, et al. Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study. Ann N Y Acad Sci 2009; 1155: 293-299.
13. Liu CJ, Hsia TC, Wang RF, Tsai CW, Chu CC, Hang LW, et al. Interaction of cyclooxygenase 2 genotype and smoking habit in Taiwanese lung cancer patients. Anticancer Res 2010; 30: 1195-1159.
14. Li Y, He W, Liu T, Zhang Q. A new cyclo-oxygenase-2 gene variant in the Han Chinese population is associated with an increased risk of gastric carcinoma. Mol Diagn Ther 2010; 14: 351-355.
15. Akkiz H, Bayram S, Bekar A, Akgöllü E, Ülger Y Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma. Mol Cell Biochem 2011; 347: 201-208.
16. Gangwar R, Mandhani A, Mttal RD. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for urinary bladder cancer in North India. Surgery 2011; 149: 126-134.
17. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000-summary of a workshop. Gastroenterology 2001; 120: 1828-1853.
18. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007; 45: 1056-1075.
19. Ke-Xiang Z, Yu-Min L, Xun L, Wen-Ce Z, Yong S, Tao L. Study on the association of COX-2 genetic polymorphisms with risk of gastric cancer in high incidence Hexi area of Gansu province in China. Mol Biol Rep 2011; 38: 649-655.
20. Lin YC, Huang HI, Wang LH, Tsai CC, Lung O, Dai CY, et al. Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population. Oral Oncol 2008; 44: 798-804.
21. He YF, Jin J, Wei W, Chang Y, Hu B, Ji CS, et al. Overexpression of cyclooxygenase-2 in noncancerous liver tissue increases the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis. Can J Gastroenterol 2010; 24: 435-440.
22. Sakaki M, Makino R, Hiroishi K, Ueda K, Eguchi J, Hiraide A, et al. Cyclooxygenase-2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progression. Hepatol Res 2010; 40: 1219-1226.
23. Fernandez P, de Beer PM, van der Merwe L, Heyns CF. COX-2 promoter polymorphisms and the association with prostate cancer risk in South African men. Carcinogenesis 2008; 29: 2347-2350.
24. Panguluri RC, Long LO, Chen W, Wang S, Coulibaly A, Ukoli F, et al. COX-2 gene promoter haplotypes and prostate cancer risk. Carcinogenesis 2004; 25: 961-966.
25. Yamauchi M, Nakahara M, Maezawa Y, Satoh S, Nishikawa F, Ohata M, et al. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol 1993; 88: 39-43.